PCSK9 and familial hypercholesterolemia: Likewise, genetically-determined aberrant expressions of PCSK9, another member of the proprotein convertase subtilisin/kexin family, have been correlated with hereditary hypercholesterolemia, severe steatosis and cardiovascular abnormalities (21–23).